tiprankstipranks
Trending News
More News >
Solasia Pharma KK (DE:9SO)
:9SO
Germany Market

Solasia Pharma KK (9SO) Financial Statements

Compare
0 Followers

Solasia Pharma KK Financial Overview

Solasia Pharma KK's market cap is currently €41.97M. The company's EPS TTM is €-0.00822894; its P/E ratio is ―; Solasia Pharma KK is scheduled to report earnings on May 14, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 316.00M¥ 617.00M¥ 1.09B¥ 559.00M¥ 454.00M
Gross Profit¥ 185.00M¥ 337.00M¥ 662.00M¥ 374.00M¥ 245.00M
Operating Income¥ -1.95B¥ -1.14B¥ -2.47B¥ -2.42B¥ -4.12B
EBITDA¥ -1.75B¥ -635.00M¥ -1.94B¥ -1.92B¥ -3.62B
Net Income¥ -1.94B¥ -1.11B¥ -2.55B¥ -2.48B¥ -4.13B
Balance Sheet
Cash & Short-Term Investments¥ 886.00M¥ 728.00M¥ 803.00M¥ 714.00M¥ 2.96B
Total Assets¥ 1.36B¥ 2.23B¥ 3.13B¥ 3.14B¥ 5.78B
Total Debt¥ 25.00M¥ 60.00M¥ 37.00M¥ 84.00M¥ 1.06B
Net Debt¥ -861.00M¥ -668.00M¥ -766.00M¥ -630.00M¥ -1.90B
Total Liabilities¥ 206.00M¥ 354.00M¥ 472.00M¥ 557.00M¥ 2.12B
Stockholders' Equity¥ 1.16B¥ 1.88B¥ 2.66B¥ 2.59B¥ 3.65B
Cash Flow
Free Cash Flow¥ -1.03B¥ -359.00M¥ -2.48B¥ -2.64B¥ -2.96B
Operating Cash Flow¥ -1.03B¥ -359.00M¥ -2.07B¥ -2.47B¥ -2.79B
Investing Cash Flow¥ 0.00¥ 2.00M¥ -418.00M¥ -164.00M¥ -171.00M
Financing Cash Flow¥ 1.18B¥ 275.00M¥ 2.57B¥ 361.00M¥ 1.83B
Currency in JPY

Solasia Pharma KK Earnings and Revenue History

Solasia Pharma KK Debt to Assets

Solasia Pharma KK Cash Flow

Solasia Pharma KK Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis